Celrixafor 24 mg Injection
$632,50
$344,51
Celrixafor 24 mg injection is a specialized medication designed to mobilize stem cells, primarily used alongside granulocyte colony-stimulating factor (G-CSF) to prepare hematopoietic stem cells for transplantation in patients battling non-Hodgkin's lymphoma and multiple myeloma. This medication contains Plerixafor, a member of the haematopoietic stem cell mobilizers class, which functions by targeting the CXCR4 chemokine receptor, effectively blocking its interaction with the ligand CXCL12. By doing so, Celrixafor facilitates the release of stem cells from the bone marrow into the bloodstream, enhancing the success rate of stem cell transplants. It is crucial to note that patients using Celrixafor should be monitored for potential side effects, such as gastrointestinal disturbances or allergic reactions. Proper administration under the guidance of a healthcare professional ensures optimal results while minimizing risks. This innovative treatment plays a vital role in improving outcomes for individuals undergoing cancer therapies, highlighting its importance in modern oncology. As with any medication, adherence to prescribed guidelines and awareness of possible warnings is essential for patient safety and efficacy.
數量
Active Pharmaceutical Ingredient
Uses
• Celrixafor 24 mg injection is primarily used to mobilize stem cells from the bone marrow into the bloodstream. This process is essential for patients undergoing stem cell transplantation. By facilitating the collection of these cells, Celrixafor helps improve the chances of a successful transplant. Medical professionals typically administer this injection shortly before the stem cell collection procedure.
• In the context of cancer treatment, Celrixafor 24 mg injection plays a critical role in enhancing the effectiveness of chemotherapy regimens. It is often administered to patients with certain types of cancers to optimize stem cell harvest. By increasing the availability of stem cells, Celrixafor aids in achieving better treatment outcomes. The timing and administration of this injection are carefully coordinated by healthcare providers.
• Celrixafor 24 mg injection is utilized in specific clinical scenarios where traditional mobilization methods may be insufficient. For instance, patients with multiple myeloma or lymphoma may benefit from this injection to ensure adequate stem cell collection. This targeted approach allows for a more personalized treatment plan. Healthcare professionals evaluate each patient’s unique situation before recommending Celrixafor.
• The administration of Celrixafor 24 mg injection occurs under strict medical supervision to ensure optimal results. It is typically given subcutaneously, allowing for effective absorption and action. The timing of the injection is crucial, often occurring just before stem cell filtration. This strategic use helps to maximize the yield of stem cells during the collection process, ultimately supporting patient recovery and treatment success.
Benefits
Autologous stem cell transplant: This is a procedure in which certain blood cells are removed from the body and then returned to the body after chemotherapy and/or radiation in people with positive cancers. A doctor or nurse will give you this Celrixafor 24 mg Injection. You should follow your doctor's instructions carefully to get the most benefit from it.
Side Effects
Side effects, which are unwanted symptoms, can be caused by taking medicines. It is important to understand that all medicines have the potential to cause side effects. However, they may not affect everyone who takes them.
Most Common Side Effects
• Constipation
• Nausea
• Dry mouth
• Numbness
• Stomach upset
• Bloating
• Lethargic
• Muscle pain
• Profuse perspiration
• Rashes
Common Side Effects
• Bleeding
• Unusual weakness
• Severe epigastric pain
• Joint pain
• Dizziness
• Burning
• Crawling
• Itching
• Vomiting
• Headache
How To Use
Plerixafor Injection 24 mg is available in an injectable form. Celrixafor 24 mg is given under the skin (subcutaneously) only under medical supervision and as directed by your doctor. Anti-cancer Drug Celrixafor is usually given 11 hours before the filtration of the blood. The dose and frequency will be determined by your doctor. It will depend on your medical condition, weight and certain other factors.
Safety Advice
• Alcohol: The safety of the use of alcohol with Celrixafor 24 mg is not known. It is advisable to have a discussion with your doctor about this.
• Kidney: Celrixafor 24 mg Injection must be used with a warning for patients with kidney disease. It may be necessary to adjust the dose of the injection. It is advisable to consult your doctor for further advice.
• Breastfeeding: Plerixafor Injection 24 mg may be dangerous to use for the duration of breastfeeding. Limited human statistics show that the drug may also pass into breast milk and harm the baby.
• Liver: Plerixafor Injection 24 mg must be used with a warning for patients with liver disease. It may be necessary to adjust the dose of the injection. It is advisable to consult your doctor for further advice.
• Pregnancy: Celrixafor 24 mg Vial should not be used during pregnancy. There is strong evidence of a risk to the developing baby. However, it may be prescribed by your doctor in rare, life-threatening situations where the benefits of use outweigh the potential risks.
• Driving: The effect of Celrixafor Injection on the ability to drive a vehicle has not been established. You should not drive if you experience symptoms that impair your concentration and reactions.